1-8 of 8
M. Weiner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Outcomes of Single-Agent Chemotherapy in a Diverse Cohort of Patients with Recalcitrant Cutaneous T-Cell Lymphoma

David M. Weiner, Andrew Ly, Sai Talluru, Richard F. Ambinder, Sima Rozati
Journal: Blood
Blood (2022) 140 (Supplement 1): 12046.
https://doi.org/10.1182/blood-2022-171218
Published: 2022
Journal Articles

Predictive Factors and Outcomes for Ibrutinib Therapy in Relapsed/Refractory Marginal Zone Lymphoma: A Multicenter Cohort Study

Narendranath Epperla, MDMS, Qiuhong Zhao, MS, Sayan Mullick Chowdhury, PhD, Tamara K. Moyo, MD, Lauren Shea, MD, Nishitha Reddy, MD MSCI, Julia Sheets, MD, David M. Weiner, BA, Praveen Ramakrishnan Geethakumari, MD MS, Malathi Kandarpa, PhD, Ximena JordanBruno, MD, Colin Thomas, MD, Michael C. Churnetski, Andrew Hsu, MD, Joseph Maakaron, MD, Paolo Caimi, MD, Pallawi Torka, MD, Celeste Bello, MD, Cherie Tan, MD, Kevin A. David, MD, Kathryn Lindsey, MD, Irl Brian Greenwell, MD, Murali Janakiram, MD, Adam J Olszewski, MD, Jonathon B. Cohen, MDMS, Neil Palmisiano, MDMS, Elvira Umyarova, MD, Ryan A. Wilcox, MD, Farrukh T Awan, MD, Stefan K. Barta, MDMRCP,MS, Natalie S Grover, MD, Nancy L. Bartlett, MD, Yazeed Sawalha, MD, Beth A. Christian, MD, Alex F. Herrera, MD, Geoffrey Shouse, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 35–36.
https://doi.org/10.1182/blood-2020-135870
Published: 2020
Journal Articles

Outcomes and Toxicities of Ibrutinib in Marginal Zone Lymphoma: A Retrospective Cohort Study at a Single Institution

David M. Weiner, BA, Nathaniel D. Robinson, MD, Steven M. Bair, MD, Hatcher J. Ballard, BS, Mitchell E. Hughes, PharmD, Sunita Dwivedy Nasta, MD, Daniel J. Landsburg, MD, Stefan K. Barta, MD MRCP, MS, Elise A. Chong, MD, Stephen J. Schuster, MD, Jakub Svoboda, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5250.
https://doi.org/10.1182/blood-2019-128556
Published: 2019
Journal Articles

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33 + targets

Michelle K. Gleason, Julie A. Ross, Erica D. Warlick, Troy C. Lund, Michael R. Verneris, Andres Wiernik, Stephen Spellman, Michael D. Haagenson, Alexander J. Lenvik, Mark R. Litzow, Pearlie K. Epling-Burnette, Bruce R. Blazar, Louis M. Weiner, Daniel J. Weisdorf, Daniel A. Vallera, Jeffrey S. Miller
Journal: Blood
Blood (2014) 123 (19): 3016–3026.
https://doi.org/10.1182/blood-2013-10-533398
Published: 2014
Includes: Supplemental data
Journal Articles

Bi-Specific Killer Cell Engagers (BiKEs) Signaling Through CD16 and Targeting CD33 (CD16 × CD33), Triggers Natural Killer (NK) Cell Cytotoxic and Cytokine Production Against Refractory Acute Myeloid Leukemia (AML)

Andres Wiernik, MD, Bree Foley, PhD, Bin Zhang, Michael R. Verneris, MD, Erica Warlick, MD, Julie A. Ross, PhD, Louis M. Weiner, MD, Daniel J. Weisdorf, MD, Daniel A Vallera, PhD, Jeffrey S. Miller, MD
Journal: Blood
Blood (2012) 120 (21): 256.
https://doi.org/10.1182/blood.V120.21.256.256
Published: 2012
Journal Articles

Neuropsychological (NP) Dysfunction and Neuroimaging Abnormalities in Neurologically Intact Adult Patients with Sickle Cell Disease (SCD).

Elliott Vichinsky, J. Gold, R. Rule, M. Weiner, B. Eggleston, A. Muma, L. Neumayr, S. Lieff, D. Bessman, K. Kalinyak, L. De Castro, T. Harrington, A. Hussein, C. Johnson, L. McMahon, E. Orringer, C. Rutherford, D. Armstrong, Comprehensive Sickle Cell Centers
Journal: Blood
Blood (2007) 110 (11): 428.
https://doi.org/10.1182/blood.V110.11.428.428
Published: 2007
Journal Articles

Rituximab-Mediated ADCC Is Augmented by Concomitant Interference with Inhibitory Self-Recognition by Human NK Cells.

Liat Binyamin, PhD, R. Katherine Alpaugh, Ph.D, Kerry S. Campbell, Ph.D, Hossein Borghaei, DO, MS, Louis M. Weiner, MD
Journal: Blood
Blood (2005) 106 (11): 2456.
https://doi.org/10.1182/blood.V106.11.2456.2456
Published: 2005
Journal Articles

The Standardized Normal Ivy Bleeding Time and Its Prolongation by Aspirin

C. H. MIELKE, JR., M.D., M. M. KANESHIRO, M.D., I. A. MAHER, B.S., J. M. WEINER, DR.P.H., S. I. RAPAPORT, M.D.
Journal: Blood
Blood (1969) 34 (2): 204–215.
https://doi.org/10.1182/blood.V34.2.204.204
Published: 1969